Study of SHR6390 in Renal Insufficiency and Healthy Subjects
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: SHR6390
Sponsor: Jiangsu HengRui Medicine Co., Ltd.